RecruitingNCT07225738

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

Studying Multiple myeloma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: City of Hope Medical Center
Principal Investigator: Richard T Lee
City of Hope Medical Center
Intervention: Non-Interventional Study(other)
Enrollment: 700 enrolled
Eligibility: 18 years · All sexes
Timeline: 2026 – 2030

Study locations (11)

CTCA at Western Regional Medical Center, Goodyear, Arizona, United States
City of Hope Medical Center, Duarte, California, United States
City of Hope Seacliff, Huntington Beach, California, United States
City of Hope at Irvine Lennar, Irvine, California, United States
City of Hope at Long Beach Elm, Long Beach, California, United States
City of Hope at Newport Beach Fashion Island, Newport Beach, California, United States
City of Hope South Pasadena, South Pasadena, California, United States
City of Hope Upland, Upland, California, United States
City of Hope West Covina, West Covina, California, United States
City of Hope Atlanta Cancer Center, Newnan, Georgia, United States
City of Hope at Chicago, Zion, Illinois, United States

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07225738 on ClinicalTrials.gov

Other trials for Multiple myeloma

Additional recruiting or active studies for the same condition.

See all trials for Multiple myeloma →

← Back to all trials